Aptamer-Based Tumor Cell Detection Assay
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tumor cell detection assays are not highly specific, sensitive, or efficient, requiring multiple steps, large sample volumes, and are costly, limiting their applicability for rapid, high-throughput, and point-of-care screening.
Innovation Solution
A novel one-step assay system using aptamer probes with an activatable reporter system that includes a quencher molecule to silence the fluorescent label until internalized by tumor cells, allowing for specific and sensitive detection of biomarkers in a small biological sample without off-target signals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If fluorescent antibodies are used for cell staining in current detection assays, then tumor cells can be detected, but constant background signals are generated that reduce sensitivity
Solution Approach 1:
The assay performs cell isolation and enrichment before staining, using magnetic beads to capture tumor cells from the sample. This preliminary separation removes most background cells that would generate off-target signals, allowing subsequent fluorescent staining to occur with minimal background interference.
Solution Approach 2:
The invention extracts and removes the source of background signals by isolating tumor cells from the bulk sample using magnetic enrichment. By separating the target cells from normal blood cells before staining, the harmful background fluorescence is eliminated while preserving the ability to detect tumor cells with high sensitivity.
2Measurement precision
If multiple-step protocols are used to achieve sufficient detection results, then detection accuracy is improved, but time and labor requirements increase
Solution Approach 1:
The assay combines multiple functions into a streamlined protocol: magnetic bead enrichment captures tumor cells while simultaneously removing background cells, and fluorescent antibodies stain the captured cells in the same reaction mixture. This merging of isolation and staining steps reduces the number of separate operations required while maintaining detection accuracy.
Solution Approach 2:
The magnetic enrichment and fluorescent staining are performed in continuous succession without intermediate washing or separation steps. The fluorescent antibodies are added directly to the magnetically enriched cell suspension, allowing the useful action of detection to continue uninterrupted and reducing total assay time while preserving accuracy.
3Quantity of substance
If large sample volumes are used for detection, then sufficient target cells are obtained for analysis, but sample consumption and cost increase
Solution Approach 1:
The magnetic beads act as artificial copies or proxies for the target tumor cells. Each bead is coated with antibodies that specifically bind to tumor cell surface markers, allowing the beads to capture and concentrate tumor cells from large sample volumes. This copying mechanism enables efficient enrichment of rare tumor cells without requiring analysis of the entire large sample volume.
Solution Approach 2:
The assay changes the concentration parameter of target cells through magnetic enrichment. By introducing magnetic beads coated with tumor-specific antibodies into the sample, the local concentration of tumor cells is dramatically increased in the bead-bound fraction, enabling detection from minimal sample volumes while maintaining sufficient target cell quantity for accurate analysis.
4Reliability
If conventional detection systems are used, then tumor cells can be identified, but off-target signals and false positives occur
Solution Approach 1:
The fluorescent signal is localized specifically to the magnetically enriched tumor cell population rather than being distributed throughout the entire sample. By concentrating tumor cells on magnetic beads and performing staining in this localized environment, the assay ensures that fluorescence signals originate only from target cells, eliminating off-target signals from normal blood cells and improving detection reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, sensitive, and specific detection of tumor cells in a single drop of blood with minimal reagents and sample volume, reducing costs and improving throughput, suitable for both clinical labs and point-of-care settings.
Implementation Method 1
an activatable reporter system that includes a quencher molecule to silence the fluorescent label until internalized by tumor cells
Data Source
AI summary
Disclosed are methods and compositions for the detection of one or more different types of cellular biomarkers in a biological sample, and in particular, methods and compositions for the rapid, one-step, highly-cell specific detection of circulating tumor cells from minute quantities of mammalian biological fluids, including, for example, from a single drop of human blood. In certain embodiments, distinctly-labeled, multi-aptamer detection reagents are provided for detecting and quantitating selected cancer cells in clinical samples such as patient specimens and/or tissues. Aptamer-based imaging methodologies are also provided for use in a variety of diagnostic assay protocols.